The University of Colorado Cancer Center is pleased to announce the return of its signature fundraising event focusing on cancers that affect women. “Libations for Life” will be held October 6, 2016 at Mile High Station in Denver.
Guest bartenders from some of Denver’s top establishments will create unique signature cocktails for the occasion. Guests will enjoy entertainment while circulating between the cocktail bars and the silent auction. “Libations for Life” will raise funds for research and treatment programs for women’s cancers at CU Cancer Center.
9News anchor Kim Christiansen is the event’s honorary chair. For years, Kim has supported breast cancer awareness efforts on behalf of 9News. The evening’s keynote speaker is Julie Clark, breast cancer survivor and creator of Baby Einstein and The Safe Side.
Although the funds from “Libations for Life” will have significant local impact, CU Cancer Center’s scientific achievements have a national reach and move the scientific community closer to new, innovative and more effective ways to cure and control cancer.
Each year, two volunteer committee chairpersons lead the committee in planning and executing the women’s event and often have a very personal interest and passion in advancing the CU Cancer Center’s mission of advancing cancer science. The 2016 event will be hosted by Emily Jordan, breast team coordinator, and Jessica Channell, Phase 1 clinical trial resource coordinator. They believe research in women’s cancers will resonate with many of the guests and hope to engage and excite people to support our research and clinical programs.
CU Cancer Center members interested in receiving funds from the 2016 “Libations for Life” are encouraged to submit requests by May 1, 2016. Please email a one page summary outlining your women’s cancer research and how the funds would be used to email@example.com . There is no minimum amount for the research budget, but the maximum should be flexible based on the net proceeds of the event. In addition, more than one project may be selected.
The 2014 women’s event raised more than $156,000 ($50,000 of which was matched by a local family foundation) and after expenses $126,000 was distributed. Past recipients of the funding include :
- Jennifer Richer, PhD, received funds for her work in androgen receptors as a driver and target in breast cancer.
- Jennifer Diamond, MD, and John Tentler, PhD, to identify novel therapeutics for patients with triple negative breast cancer.
- Heide Ford, PhD, to develop novel inhibitors targeting the Six1/Eya protein interaction and the Eya phosphatase to inhibit breast cancer progression.